Works matching DE "BARICITINIB"
Results: 334
Correlation between knowledge level, side effect severity, family support, and antiretroviral therapy adherence in HIV/AIDS patients in Greater Malang, East Java, Indonesia.
- Published in:
- Pharmacia (0428-0296), 2023, v. 70, n. 4, p. 1213, doi. 10.3897/pharmacia.70.e112645
- By:
- Publication type:
- Article
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib.
- Published in:
- Pharmacia (0428-0296), 2023, v. 70, n. 4, p. 1177, doi. 10.3897/pharmacia.70.e112550
- By:
- Publication type:
- Article
Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.980247
- By:
- Publication type:
- Article
Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1008392
- By:
- Publication type:
- Article
Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Treatment of active systemic lupus erythematosus with baricitinib: A meta-analysis of randomized controlled trials.
- Published in:
- Lupus, 2023, v. 32, n. 13, p. 1493, doi. 10.1177/09612033231208842
- By:
- Publication type:
- Article
Baricitinib treatment linked to reduced mortality in COVID-19 patients.
- Published in:
- Pulse International, 2020, v. 21, n. 23, p. N.PAG
- Publication type:
- Article
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THE DETERMINATION OF BARICITINIB AND ITS RELATED DRUG SUBSTANCES.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1163, doi. 10.31788/RJC.2023.1638344
- By:
- Publication type:
- Article
Crystal structure of baricitinib, C16H17N7O2S.
- Published in:
- Powder Diffraction, 2022, v. 37, n. 3, p. 150, doi. 10.1017/S088571562200015X
- By:
- Publication type:
- Article
Model of Chronic Itch in Aged Mice: Beneficial Effects of Drugs Affecting Descending Modulatory Systems.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.39950
- By:
- Publication type:
- Article
Impact of Baricitinib on Patients’ Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.14153
- By:
- Publication type:
- Article
Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.9646
- By:
- Publication type:
- Article
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5243
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.4536
- By:
- Publication type:
- Article
Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.3978
- By:
- Publication type:
- Article
Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1088
- By:
- Publication type:
- Article
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study.
- Published in:
- Pigment Cell & Melanoma Research, 2025, v. 38, n. 1, p. 1, doi. 10.1111/pcmr.13209
- By:
- Publication type:
- Article
Real-world comparative study of drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0306714
- By:
- Publication type:
- Article
The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0305621
- By:
- Publication type:
- Article
Baricitinib as the first systemic treatment for severe alopecia areata.
- Published in:
- Expert Review of Clinical Immunology, 2023, v. 19, n. 6, p. 565, doi. 10.1080/1744666X.2023.2200166
- By:
- Publication type:
- Article
What is the full potential of baricitinib in treating patients with COVID-19?
- Published in:
- Expert Review of Clinical Immunology, 2022, v. 18, n. 6, p. 545, doi. 10.1080/1744666X.2022.2072298
- By:
- Publication type:
- Article
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 13, p. 7273, doi. 10.3390/ijms25137273
- By:
- Publication type:
- Article
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7474, doi. 10.3390/ijms22147474
- By:
- Publication type:
- Article
Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6632, doi. 10.3390/ijms21186632
- By:
- Publication type:
- Article
Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro.
- Published in:
- BMC Cardiovascular Disorders, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12872-025-04517-x
- By:
- Publication type:
- Article
Synthesis of [<sup>2</sup>H<sub>5</sub>]baricitinib via [<sup>2</sup>H<sub>5</sub>]ethanesulfonyl chloride.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 6, p. 156, doi. 10.1002/jlcr.3969
- By:
- Publication type:
- Article
A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-α inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 12, p. 3657, doi. 10.1007/s10067-024-07194-x
- By:
- Publication type:
- Article
Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 2133, doi. 10.1007/s10067-024-06980-x
- By:
- Publication type:
- Article
Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 775, doi. 10.1007/s10067-023-06773-8
- By:
- Publication type:
- Article
Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 2, p. 579, doi. 10.1007/s10067-023-06731-4
- By:
- Publication type:
- Article
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 12, p. 3225, doi. 10.1007/s10067-023-06787-2
- By:
- Publication type:
- Article
A case of hemophagocytic lymphohistiocytosis with a significant response to baricitinib: a first report with review of literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 6, p. 1659, doi. 10.1007/s10067-022-06096-0
- By:
- Publication type:
- Article
Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3143, doi. 10.1007/s10067-021-05815-3
- By:
- Publication type:
- Article
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 7, p. 2673, doi. 10.1007/s10067-021-05609-7
- By:
- Publication type:
- Article
Baricitinib combined with methylprednisolone on inflammatory factors in patients with severe pneumonia.
- Published in:
- Advances in Continuous & Discrete Models, 2025, v. 2025, n. 1, p. 1, doi. 10.1186/s13662-025-03904-0
- By:
- Publication type:
- Article
Emerging Insights: The Impact of Real-world Evidence on Rheumatoid Arthritis. Latest Evidence from Janus Kinase (JAK) Inhibitors.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Therapeutic Maintenance of Janus Kinase Inhibitors in Real Life for Rheumatoid Arthritis: Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4608, doi. 10.3390/jcm13164608
- By:
- Publication type:
- Article
The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2517, doi. 10.3390/jcm13092517
- By:
- Publication type:
- Article
Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6690, doi. 10.3390/jcm12206690
- By:
- Publication type:
- Article
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4527, doi. 10.3390/jcm12134527
- By:
- Publication type:
- Article
Effectiveness of baricitinib in acquired reactive perforating collagenosis: a case report.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1388274
- By:
- Publication type:
- Article
Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1395288
- By:
- Publication type:
- Article
Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1341632
- By:
- Publication type:
- Article
Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1223014
- By:
- Publication type:
- Article
Dupilumab in Combination With JAK Inhibitor for Refractory Moderate‐to‐Severe Atopic Dermatitis.
- Published in:
- Dermatologic Therapy, 2024, v. 2024, p. 1, doi. 10.1155/dth/9515524
- By:
- Publication type:
- Article
Baricitinib for the Treatment of Chronic Pruritus of Unknown Origin: A Retrospective Study.
- Published in:
- Dermatologic Therapy, 2024, v. 2024, p. 1, doi. 10.1155/2024/5531111
- By:
- Publication type:
- Article
Reply to: Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series.
- Published in:
- International Journal of Dermatology, 2025, v. 64, n. 1, p. 218, doi. 10.1111/ijd.17594
- By:
- Publication type:
- Article
Clinical effectiveness of combined dupilumab and baricitinib in a patient with multi‐drug resistant severe atopic dermatitis.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 12, p. 1783, doi. 10.1111/ijd.17250
- By:
- Publication type:
- Article